Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Liver Failure [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating transplantation of umbilical cord mesenchymal stem cells in combination with plasma exchange for liver failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Liver Failure | Phase 1, Phase 2 | Status: UNKNOWN